Rapafucin derivative compounds and methods of use thereof
US-12540144-B2 · Feb 3, 2026 · US
Rapafusyn Pharmaceuticals Inc holds 5 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 5 |
| Recent patents | 3 |
| First publication | Jul 20, 2021 |
| Latest publication | Feb 3, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12540144-B2 · Feb 3, 2026 · US
US-2024239810-A1 · Jul 18, 2024 · US
US-11945827-B2 · Apr 2, 2024 · US
US-2022363692-A1 · Nov 17, 2022 · US
US-11066416-B2 · Jul 20, 2021 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12540144-B2 · Feb 3, 2026 · US
US-2024239810-A1 · Jul 18, 2024 · US
US-11945827-B2 · Apr 2, 2024 · US
US-2022363692-A1 · Nov 17, 2022 · US
US-11066416-B2 · Jul 20, 2021 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C07F9/3258 | 5 |
| C07D498/04 | 5 |
| C07D498/14 | 5 |
| C07F9/6561 | 5 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 5 |
Answers are generated from the same data shown on this page.